In Vitro Antimicrobial Susceptibility to Isepamicin of 6,296 Enterobacteriaceae Clinical Isolates Collected at a Tertiary Care University Hospital in Greece
Antimicrobial Agents and Chemotherapy, 05/17/2012Maraki S et al.
Isepamicin exhibited high in vitro activity against almost all of the Enterobacteriaceae species. It could particularly serve as a last–resort therapeutic option for carbapenem–resistant K. pneumoniae in the region, where it is endemic, as it does not show considerable cross–resistance with other aminoglycosides.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.